Press Releases

Reviva Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Sep 02, 2021

Reviva Pharmaceuticals Holdings, Inc. Reports Second Quarter 2021 Financial Results and Recent Business Highlights

Aug 16, 2021

Reviva Added to Russell Microcap® Index

Jun 28, 2021

Reviva Announces Pricing of Upsized $30 Million Underwritten Public Offering

May 26, 2021

Reviva Announces Full Details of Positive Phase 2 Clinical Trial Results for Acute Schizophrenia

Apr 26, 2021

Reviva Pharmaceuticals Holdings, Inc. Reports 2020 Financial Results and Provides Corporate Update

Mar 22, 2021

Reviva Pharmaceuticals Holdings, Inc. to Present at the Maxim Group Inaugural 2021 Emerging Growth Virtual Conference

Mar 11, 2021

Reviva Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference

Mar 04, 2021

Reviva Pharmaceuticals, Inc. and Tenzing Acquisition Corp. Complete their Business Combination and Trade as Reviva Pharmaceuticals Holdings, Inc.

Dec 14, 2020

Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce the Appointment of Narayan Prabhu as Chief Financial Officer

Nov 04, 2020